MR/TRUS Fusion Guided Prostate Biopsy – An Improved Way to Detect and Quantify Prostate Cancer

Clinical Trials, High Risk Prostate Cancer, Intermediate Risk Prostate Cancer, Low Risk Prostate Cancer

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT04599218
Phase: NA
Trial Summary: This research study is designed to determine if targeted Magnetic Resonance Imaging (MRI) Ultrasound (US) fusion biopsy is better than the standard of care ultrasound guided biopsy alone in diagnosing – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Ardeshir Rastinehad
Acronym:

Pin It on Pinterest